Adam Kroetsch is a Research Director at the Duke-Robert J. Margolis, MD, Center for Health Policy in Washington, DC, where he oversees the Center’s portfolio of research on biomedical innovation and regulatory science, including research on pharmaceutical quality and drug shortages. Before joining the Duke-Margolis Center, Adam worked at the FDA for over a decade. Most recently, Adam served as the deputy director of the FDA Drug Center’s Office of Program and Strategic Analysis, in which he supported the agency’s efforts to address drug shortages through policy analysis, modeling, and analytics.